The cardiovascular pharmacology of lidoflazine, a long-acting coronary vasodilator.
Schaper Wk, R Xhoneux, Jageneau Ah, Patricia A. Janssen
Abstract
Schaper Wk, R Xhoneux, Jageneau Ah, Patricia A. Janssen
Abstract
A series of cardiovascular experiments with lidoflazine (R 7904) in anesthetized and unanesthetized dogs is described in detail. The results indicate that lidoflazine is a specific, orally active and very long-acting coronary vasodilating agent. It acts directly on the smooth muscles of the coronary vessels. Lidoflazine is chemically unrelated to the known coronary vasodilators.
OpenAlex reports 54 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
A series of cardiovascular experiments with lidoflazine (R 7904) in anesthetized and unanesthetized dogs is described in detail. The results indicate that lidoflazine is a specific, orally active and very long-acting coronary vasodilating agent. It acts directly on the smooth muscles of the coronary vessels. Lidoflazine is chemically unrelated to the known coronary vasodilators.
Key concepts: Vasodilation, Coronary vasodilator, Vasodilator agents, Cardiology, Medicine, Pharmacology, Internal medicine, Coronary circulation